메뉴 건너뛰기




Volumn 25, Issue 9, 2007, Pages 1054-1060

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; POTASSIUM IODIDE; POTASSIUM PERCHLORATE; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

EID: 34047214104     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.3484     Document Type: Article
Times cited : (217)

References (29)
  • 1
    • 4444357091 scopus 로고    scopus 로고
    • Neuroblastoma
    • Bast RC, Kufe DW, Pollock RE, et al eds, London, BC Decker
    • Matthay KK, Yamashiro D: Neuroblastoma, in Bast RC, Kufe DW, Pollock RE, et al (eds): Cancer Medicine. London, BC Decker, 2000, pp 2185-2197
    • (2000) Cancer Medicine , pp. 2185-2197
    • Matthay, K.K.1    Yamashiro, D.2
  • 2
    • 0033554684 scopus 로고    scopus 로고
    • Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
    • Matthay KK, Villablanca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341:1165-1173, 1999
    • (1999) N Engl J Med , vol.341 , pp. 1165-1173
    • Matthay, K.K.1    Villablanca, J.G.2    Seeger, R.C.3
  • 3
    • 0018908664 scopus 로고
    • Radiolabeled adrenergic neuron-labeling agents: Adrenomedullary imaging with 131-I-iodobenzylguanidine
    • Wieland DM, Wu JL, Brown LE, et al: Radiolabeled adrenergic neuron-labeling agents: Adrenomedullary imaging with 131-I-iodobenzylguanidine. J Nucl Med 21:349-353, 1980
    • (1980) J Nucl Med , vol.21 , pp. 349-353
    • Wieland, D.M.1    Wu, J.L.2    Brown, L.E.3
  • 4
    • 0031961810 scopus 로고    scopus 로고
    • Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
    • Matthay KK, DeSantes K, Hasegawa B, et al: Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol 16:229-236, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 229-236
    • Matthay, K.K.1    DeSantes, K.2    Hasegawa, B.3
  • 5
    • 0032585696 scopus 로고    scopus 로고
    • 131I- metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients
    • Garaventa A, Bellagamba O, Lo Piccolo MS, et al: 131I- metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients. Br J Cancer 81:1378-1384, 1999
    • (1999) Br J Cancer , vol.81 , pp. 1378-1384
    • Garaventa, A.1    Bellagamba, O.2    Lo Piccolo, M.S.3
  • 6
    • 0025868778 scopus 로고
    • Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German Neuroblastoma Trial
    • Klingebiel T, Berthold F, Treuner J, et al: Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German Neuroblastoma Trial. Med Pediatr Oncol 19:84-88, 1991
    • (1991) Med Pediatr Oncol , vol.19 , pp. 84-88
    • Klingebiel, T.1    Berthold, F.2    Treuner, J.3
  • 7
    • 0026357907 scopus 로고
    • Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma
    • Hutchinson RJ, Sisson JC, Miser JS, et al: Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. J Nucl Biol Med 35:237-240, 1991
    • (1991) J Nucl Biol Med , vol.35 , pp. 237-240
    • Hutchinson, R.J.1    Sisson, J.C.2    Miser, J.S.3
  • 8
    • 0025984214 scopus 로고
    • Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy
    • Voute PA, Hoefnagel CA, de Kraker J, et al: Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Prog Clin Biol Res 366:439-445, 1991
    • (1991) Prog Clin Biol Res , vol.366 , pp. 439-445
    • Voute, P.A.1    Hoefnagel, C.A.2    de Kraker, J.3
  • 9
    • 0027093713 scopus 로고
    • Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation
    • Lashford LS, Lewis IJ, Fielding SL, et al: Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation. J Clin Oncol 10:1889-1896, 1992
    • (1992) J Clin Oncol , vol.10 , pp. 1889-1896
    • Lashford, L.S.1    Lewis, I.J.2    Fielding, S.L.3
  • 10
    • 0026405073 scopus 로고
    • Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: A phase II study in 26 patients. Societe Francaise d'Oncologie Pediatrique and Nuclear Medicine Co-investigators
    • Lumbroso J, Hartmann O, Schlumberger M: Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: A phase II study in 26 patients. Societe Francaise d'Oncologie Pediatrique and Nuclear Medicine Co-investigators. J Nucl Biol Med 35:220-223, 1991
    • (1991) J Nucl Biol Med , vol.35 , pp. 220-223
    • Lumbroso, J.1    Hartmann, O.2    Schlumberger, M.3
  • 11
    • 0028169019 scopus 로고
    • 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients
    • Hoefnagel CA, De Kraker J, Valdes Olmos RA, et al: 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients. Nucl Med Commun 15: 712-717, 1994
    • (1994) Nucl Med Commun , vol.15 , pp. 712-717
    • Hoefnagel, C.A.1    De Kraker, J.2    Valdes Olmos, R.A.3
  • 12
    • 0035099689 scopus 로고    scopus 로고
    • Treatment of advanced neuroblastoma: Feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy
    • Mastrangelo S, Tornesello A, Diociaiuti L, et al: Treatment of advanced neuroblastoma: Feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer 84:460-464, 2001
    • (2001) Br J Cancer , vol.84 , pp. 460-464
    • Mastrangelo, S.1    Tornesello, A.2    Diociaiuti, L.3
  • 13
    • 0032145478 scopus 로고    scopus 로고
    • Treatment of neuroblastoma stage 4 with 131I-metaiodo-benzylguanidine, high-dose chemotherapy and immunotherapy: A pilot study
    • Klingebiel T, Bader P, Bares R, et al: Treatment of neuroblastoma stage 4 with 131I-metaiodo-benzylguanidine, high-dose chemotherapy and immunotherapy: A pilot study. Eur J Cancer 34: 1398-1402, 1998
    • (1998) Eur J Cancer , vol.34 , pp. 1398-1402
    • Klingebiel, T.1    Bader, P.2    Bares, R.3
  • 14
    • 0037089597 scopus 로고    scopus 로고
    • Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma
    • Yanik GA, Levine JE, Matthay KK, et al: Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J Clin Oncol 20:2142-2149, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 2142-2149
    • Yanik, G.A.1    Levine, J.E.2    Matthay, K.K.3
  • 15
    • 33644846781 scopus 로고    scopus 로고
    • Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
    • Matthay KK, Tan JC, Villablanca JG, et al: Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol 24: 500-506, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 500-506
    • Matthay, K.K.1    Tan, J.C.2    Villablanca, J.G.3
  • 16
    • 18844423539 scopus 로고    scopus 로고
    • Feasibility of dosimetry-based high-dose 131I-metaiodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma
    • Gaze MN, Chang YC, Flux GD, et al: Feasibility of dosimetry-based high-dose 131I-metaiodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma. Cancer Biother Radiopharm 20:195-199, 2005
    • (2005) Cancer Biother Radiopharm , vol.20 , pp. 195-199
    • Gaze, M.N.1    Chang, Y.C.2    Flux, G.D.3
  • 17
    • 2942702182 scopus 로고    scopus 로고
    • Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma
    • Dubois SG, Messina J, Maris JM, et al: Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma. J Clin Oncol 22:2452-2460, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 2452-2460
    • Dubois, S.G.1    Messina, J.2    Maris, J.M.3
  • 18
    • 0035205508 scopus 로고    scopus 로고
    • Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG
    • Matthay KK, Panina C, Huberty J, et al: Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med 42: 1713-1721, 2001
    • (2001) J Nucl Med , vol.42 , pp. 1713-1721
    • Matthay, K.K.1    Panina, C.2    Huberty, J.3
  • 19
    • 13444303822 scopus 로고    scopus 로고
    • Tumor response and toxicity with multiple infusions of high dose (131)I-MIBG for refractory neuroblastoma
    • Howard JP, Maris JM, Kersun LS, et al: Tumor response and toxicity with multiple infusions of high dose (131)I-MIBG for refractory neuroblastoma. Pediatr Blood Cancer 44:232-239, 2005
    • (2005) Pediatr Blood Cancer , vol.44 , pp. 232-239
    • Howard, J.P.1    Maris, J.M.2    Kersun, L.S.3
  • 20
    • 0027239723 scopus 로고
    • Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
    • Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 1466-1477
    • Brodeur, G.M.1    Pritchard, J.2    Berthold, F.3
  • 21
    • 33750483287 scopus 로고    scopus 로고
    • Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
    • Messina JA, Cheng SC, Franc BL, et al: Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer 47: 865-874, 2006
    • (2006) Pediatr Blood Cancer , vol.47 , pp. 865-874
    • Messina, J.A.1    Cheng, S.C.2    Franc, B.L.3
  • 22
    • 0034671344 scopus 로고    scopus 로고
    • Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: A Children's Cancer Group Study
    • Seeger RC, Reynolds CP, Gallego R, et al: Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: A Children's Cancer Group Study. J Clin Oncol 18:4067-4076, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 4067-4076
    • Seeger, R.C.1    Reynolds, C.P.2    Gallego, R.3
  • 23
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 24
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DRB: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
    • (1972) J R Stat Soc B , vol.34 , pp. 187-220
    • Cox, D.R.B.1
  • 25
    • 0038649080 scopus 로고    scopus 로고
    • Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma
    • Weiss B, Vora A, Huberty J, et al: Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. J Pediatr Hematol Oncol 25:543-547, 2003
    • (2003) J Pediatr Hematol Oncol , vol.25 , pp. 543-547
    • Weiss, B.1    Vora, A.2    Huberty, J.3
  • 26
    • 0030919377 scopus 로고    scopus 로고
    • Neuroblastoma in adults and adolescents: An indolent course with poor survival
    • Franks LM, Bollen A, Seeger RC, et al: Neuroblastoma in adults and adolescents: An indolent course with poor survival. Cancer 79:2028-2035, 1997
    • (1997) Cancer , vol.79 , pp. 2028-2035
    • Franks, L.M.1    Bollen, A.2    Seeger, R.C.3
  • 27
    • 0027528534 scopus 로고
    • Second tumors after treatment of childhood malignancies
    • Robison LL, Mertens A: Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am 7:401-415, 1993
    • (1993) Hematol Oncol Clin North Am , vol.7 , pp. 401-415
    • Robison, L.L.1    Mertens, A.2
  • 28
    • 0035253384 scopus 로고    scopus 로고
    • How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review
    • Kushner BH, Meyers PA: How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 19:870-880, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 870-880
    • Kushner, B.H.1    Meyers, P.A.2
  • 29
    • 0037445124 scopus 로고    scopus 로고
    • Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique
    • Le Deley MC, Leblanc T, Shamsaldin A, et al: Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21:1074-1081, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 1074-1081
    • Le Deley, M.C.1    Leblanc, T.2    Shamsaldin, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.